IJ Pharmaceutical Research

IJ Pharmaceutical Research

Overview

Scientific Collaborator: School of Pharmacy, SBMU
ISSN: e: 1726-6890 | p: 1735-0328
Frequency: annually

Abstracted/Indexed: ISI Web of Science (SCIE) | Scopus | PubMed | EMBASE | DOAJ | EBSCO | Chemical Abstracts | IMEMR | Biosis Previews | IPA | EMR medex | EMRO | Open J-Gate | Scientific Information Database (SID) | ISC | Google Scholar,  more


Scope: All aspects of pharmaceutical sciences, more

submit manuscript
IF, JCR 2022
CiteScore 2022
3.6
Submission to Final Decision (Days):
20
Acceptance to Publication (Days):
16
Acceptance Rate (%) :
11.42
Open Peer Review (Articles) :
41
Acceptance Fee (From €) :
900

recent articles

vol. 23 , issue 1
4 articles
2024
21
Feb
2024
Iran J Pharm Res

Efficacy and Safety of A DOAC Compared to Unfractionated Heparin and A Low Molecular Weight Heparin in the Prevention of Thromboembolism in Hematopoietic Stem Cell Transplant Recipients

Saeed Azimi ORCID , Abbas Hajifathali ORCID , Sayeh Parkhideh, Jamshid Salamzadeh ORCID , Bardia Rahmati Kamel, Farzaneh Dastan ORCID , et al.
|
Uncorrected Proof scheduled for 23 (1)
17
Feb
2024
Iran J Pharm Res

Design and Characterization of an Osmotic Pump System for Optimal Feeding and pH Control in E. coli Culture to Increase Biomass

Saeedeh Abedin ORCID , Javad Ranjbari ORCID , Azadeh Haeri ORCID , Hossein Vahidi, Hamidreza Moghimi ORCID *
|
Uncorrected Proof scheduled for 23 (1)
27
Feb
2024
Iran J Pharm Res

A Long-Lasting Triamcinolone-Loaded Microneedle Patch for Prolonged Dermal Delivery

Nasrin Zarei Chamgordani ORCID , Sasan Asiaei ORCID , Fatemeh Ghorbani-Bidkorpeh ORCID , Masoud Babaee Foroutan, Mostafa Dahmardehei, Hamid Reza Moghimi ORCID *
|
Uncorrected Proof scheduled for 23 (1)
27
Feb
2024

Erratum: Review on Approved and Inprogress COVID-19 Vaccines

Soraya Shahhosseini *
|
Final Published